Latest CDKAB Guidelines You Should Know
In Indonesia’s growing medical device market, quality assurance is no longer optional—it’s mandatory. As the industry expands to meet healthcare demands, the government has updated its regulatory framework to ensure medical devices are distributed and managed in a safe, controlled, and traceable manner. This is where CDAKB, or Good Distribution Practices for Medical Devices, comes into play. Understanding the latest CDAKB guidelines is essential for importers, distributors, and all stakeholders involved in the medical device supply chain.
[caption id="attachment_7970" align="aligncenter" width="512"]
Image source: Freepik[/caption]
CDAKB is issued by the Indonesian Ministry of Health and aligns with international standards to ensure the integrity of medical devices from the point of production to their delivery and use. Whether you are renewing your CDAKB certification, entering the Indonesian market, or managing distribution operations, knowing the current updates is crucial to remain compliant and competitive. This article outlines the most recent CDAKB changes and highlights what businesses must focus on to meet the 2024–2025 regulatory expectations.
Key Changes in the Latest CDAKB Guidelines
One of the most significant updates to the CDAKB framework is the strengthening of traceability requirements. Distributors are now required to implement systems that allow every medical device to be tracked throughout the entire supply chain. This includes detailed documentation of batch numbers, serial codes, expiration dates, delivery dates, and end-user information. These updates are designed to support faster product recalls, improve inventory control, and increase transparency for regulators. Manual recordkeeping is no longer sufficient—digital traceability systems are now recommended.
Another important addition is the mandatory appointment of a qualified Technical Person in Charge (TPC), known locally as Penanggung Jawab Teknis (PJT). This individual must have a relevant academic background, such as pharmacy, biomedical engineering, or related fields, and be responsible for overseeing technical operations. According to the new CDAKB standards, the TPC must also attend updated training modules certified by the Ministry of Health or appointed institutions. Failure to appoint a qualified TPC can result in suspension of distribution licenses.
A third major guideline update involves the enhanced requirements for storage and transport conditions. Companies must now demonstrate that their facilities and vehicles can maintain the environmental conditions specified by the device manufacturers. For example, temperature-sensitive products such as diagnostic kits and vaccines must be stored and transported within approved temperature ranges, and evidence of monitoring (e.g., data loggers or sensors) must be available for inspection. These standards aim to reduce product degradation and ensure patient safety.
Operational Practices Distributors Must Implement
One of the core practices now emphasized in the guidelines is the requirement to establish and document Standard Operating Procedures (SOPs) across all stages of distribution. Every activity—from receiving and inspecting goods to storing, packing, shipping, and handling product returns—must be governed by approved SOPs. These documents must be regularly reviewed, updated, and followed by all employees. Auditors will verify if procedures are not only documented but also actively implemented in daily operations.
Another operational enhancement is the strengthening of internal audit systems. Distributors are required to conduct scheduled internal audits to review compliance with CDAKB principles. These audits should cover infrastructure, documentation, staff training, product handling, and customer complaint resolution. The results of these audits must be documented, and any identified non-conformities must have clear corrective actions. This approach ensures continuous improvement and regulatory readiness at all times.
A final key operational focus is the implementation of risk management protocols in distribution activities. The updated CDAKB guidelines require companies to identify and assess potential risks—such as stockouts, temperature excursions, product mix-ups, and security threats—and establish mitigation strategies. Risk management plans should be integrated into quality systems and reviewed periodically. This focus on preventive measures ensures that distributors are prepared for disruptions and can maintain service reliability and patient safety.
Importance of Quality Management Systems in CDAKB
A central pillar of the latest CDAKB guidelines is the requirement to establish a formal Quality Management System (QMS) that meets the specific needs of medical device distribution. While ISO 13485 is not mandatory, its structure provides a strong foundation for implementing a QMS under CDAKB. The system must include procedures for document control, change management, CAPA (Corrective and Preventive Action), and quality review meetings. Organizations are expected to demonstrate not just the existence, but also the active use of the QMS.
Another QMS enhancement is the requirement for competency-based training programs. All personnel involved in warehousing, transport, technical supervision, or quality control must undergo initial and periodic training. This ensures staff are up to date with the latest CDAKB expectations, understand SOPs, and are capable of executing their roles effectively. Training records and evaluations must be documented and made available during audits. The emphasis is now on staff competency—not just employment history.
Additionally, companies must show management commitment to quality goals. This includes assigning adequate resources, holding routine reviews of CDAKB performance indicators, and promoting a culture of compliance and improvement. The leadership team must be able to demonstrate their involvement and awareness of CDAKB-related metrics, making it clear that regulatory compliance is a strategic business objective, not just a technical function.
Compliance Documentation and Audit Readiness
A critical area emphasized in the updated guidelines is complete and accurate documentation. From incoming goods inspection logs and temperature monitoring sheets to complaint handling reports and product release authorizations, all records must be maintained in physical or digital formats and retained for a minimum period defined by regulation. Any missing or poorly maintained documentation can lead to audit failures, warnings, or even certification withdrawal.
CDAKB audits now require evidence of continual monitoring and improvement activities. Inspectors are tasked with evaluating not just whether compliance exists, but how consistently it is applied. Companies must show logs of internal quality audits, customer feedback analysis, deviation reports, and action follow-up. This evolution reflects a shift from a one-time certification approach to an ongoing performance-based compliance model.
The guidelines also push for electronic systems to manage documentation and traceability. Although paper-based systems are still allowed, digital systems that offer version control, access tracking, and real-time updates are highly encouraged. These systems enhance accuracy, reduce human error, and make it easier to respond to audit requests or market recalls. CDAKB-compliant companies are therefore investing in software tools that support data integrity, automation, and regulatory responsiveness.
Integration with National Health Procurement Systems
The CDAKB framework is closely linked to the government’s electronic procurement platform, e-Katalog, overseen by Indonesia’s National Public Procurement Agency (LKPP). Distributors that wish to participate in public tenders or supply government hospitals must hold valid CDAKB certification. As part of the latest alignment, CDAKB audits now assess whether distributors can support the service level expectations of e-Katalog contracts, including product availability, delivery timelines, and after-sales service.
[caption id="attachment_7972" align="aligncenter" width="569"]
Image source: Freepik[/caption]
The updated guidelines also require real-time stock monitoring and reporting mechanisms for distributors participating in national programs. This ensures that the Ministry of Health and hospital procurement officers can track inventory and avoid shortages. Distributors must show that they can maintain minimum stock levels and respond quickly to high-demand scenarios especially for critical items like emergency devices, diagnostics, and COVID-related supplies.
Moreover, CDAKB compliance strengthens public trust and competitive advantage in the government sector. Certified companies are more likely to win contracts and build long-term partnerships with public institutions. With increasing emphasis on quality and accountability, a CDAKB certificate is no longer just a legal requirement—it is a strategic asset for growth in Indonesia’s healthcare supply market.
Staying Ahead with the New CDAKB Landscape
The latest CDAKB guidelines are more than just regulatory updates—they represent a shift toward higher accountability, digital readiness, and long-term quality assurance in Indonesia’s healthcare supply chain. From advanced traceability systems and TPC qualifications to QMS implementation and government procurement integration, the new requirements are reshaping how medical devices are handled, stored, and delivered nationwide.
For distributors and importers, the path to compliance may involve significant investment in systems, training, and infrastructure. However, these efforts are essential not only to pass audits but to deliver safe, effective medical devices to the people who need them most. By embracing the updated CDAKB standards, organizations signal their commitment to healthcare excellence, business integrity, and patient safety.
Contact Naramedic for further consultation.
